Literature DB >> 20530177

Effect and sustainability of part-time occlusion therapy for patients with anisometropic amblyopia aged > or =8 years.

D J Hwang1, Y J Kim, J Y Lee.   

Abstract

AIMS: To study the effect and long-term sustainability of part-time occlusion therapy for anisometropic amblyopia after 8 years of age.
METHODS: A total of 41 anisometropic amblyopes aged > or =8 years were analysed. In six patients, best-corrected visual acuity (BCVA) of amblyopic eye improved more than two lines within 2 weeks of full-time spectacle wear. The remaining patients were assigned to perform part-time patching during out-of-school hours. Long-term results were assessed in patients who were observed over 1 year after the end of the treatment.
RESULTS: Among 35 patients, four dropped out, refusing further treatment, and one changed to atropine penalisation. The part-time patching schedule was completed in 30 patients. 90% of patients (27/30) complied well. Mean BCVA in the amblyopic eye improved significantly (p<0.001), and 96.7% of patients (29/30) achieved the final BCVA of 0.1 logMAR or better. In long-term results, 87% preserved the BCVA of 0.1 logMAR or better. None of four dropouts achieved the BCVA of 0.1 logMAR or better in long-term results even on the continuous spectacle wear.
CONCLUSIONS: The part-time occlusion treatment in school-aged amblyopes, which had been carried out after school hours, was successful and the effect was sustained in most cases.

Entities:  

Mesh:

Year:  2010        PMID: 20530177     DOI: 10.1136/bjo.2009.167817

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  2 in total

1.  Objective measurement of spectacle wear with a temperature sensor data logger.

Authors:  Matthew J Lentsch; Jason D Marsack; Heather A Anderson
Journal:  Ophthalmic Physiol Opt       Date:  2017-11-08       Impact factor: 3.117

Review 2.  The relationship between anisometropia and amblyopia.

Authors:  Brendan T Barrett; Arthur Bradley; T Rowan Candy
Journal:  Prog Retin Eye Res       Date:  2013-06-15       Impact factor: 21.198

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.